| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | 0.18 | 3e-07 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | 0.18 | 1e-06 |
| mRNA | UNC0638 | GDSC1000 | pan-cancer | AAC | 0.16 | 6e-06 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | 0.17 | 9e-06 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | 0.17 | 9e-06 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | 0.16 | 2e-05 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | 0.15 | 3e-05 |
| mRNA | ISOX | CTRPv2 | pan-cancer | AAC | 0.14 | 6e-05 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.13 | 9e-05 |
| mRNA | SN-38 | GDSC1000 | pan-cancer | AAC | 0.15 | 0.0001 |